Learn why high-cost specialty drugs for chronic diseases are often mail-order only. Updated for 2026 with FTC findings, PBM reform, biosimilar trends, and the latest distribution network data.
Updated 2026 guide to US mail-order specialty pharmacies. Covers $751B market, top players (CVS, Optum, Express Scripts), FTC PBM reform, Walgreens-Sycamore split, GLP-1 growth, and specialty drug distribution trends.
Learn what specialty pharmacy is, how it differs from retail, and its role in managing high-cost specialty medications. Updated for 2026 with the latest on GLP-1 drugs, FTC PBM reforms, IRA out-of-pocket caps, and gene therapy growth.
An in-depth analysis of the specialty pharmacy industry covering key players (PBMs, distributors), market trends, biosimilar competition, PBM reform, and the economics of high-cost specialty drugs. Updated March 2026.
A guide to the top 10 specialty pharmacy management platforms in 2025-2026. We compare systems from WellSky & McKesson to AI-powered tools like House Rx, Mandolin & Lamar Health for prior authorization & patient care
© 2026 IntuitionLabs. All rights reserved.
